Grantham, Mayo, Van Otterloo & Co (GMO)
VRN

Grantham, Mayo, Van Otterloo & Co (GMO)’s Veren VRN Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio VRN Stock Details VRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,908,929
Closed -$25.9M – 698
2025
Q1 		$25.9M Buy
+3,908,929
New +$21.6M 0.08% 155
2024
Q4 		– Sell
-432,520
Closed -$2.66M – 620
2024
Q3 		$2.66M Sell
432,520
-400,687
-48% -$2.86M 0.01% 354
2024
Q2 		$6.56M Sell
833,207
-904,100
-52% -$7.61M 0.02% 296
2024
Q1 		$14.2M Buy
1,737,307
+682,007
+65% +$4.78M 0.05% 226
2023
Q4 		$7.31M Buy
+1,055,300
New +$7.79M 0.03% 263
2023
Q2 		– Sell
-1,023,394
Closed -$7.23M – 758
2023
Q1 		$7.23M Sell
1,023,394
-238,100
-19% -$1.65M 0.04% 284
2022
Q4 		$9.02M Buy
1,261,494
+617,500
+96% +$4.58M 0.05% 249
2022
Q3 		$3.97M Sell
643,994
-1,500
-0.2% -$10.7K 0.02% 358
2022
Q2 		$4.6M Buy
+645,494
New +$5.06M 0.02% 354
2022
Q1 		– Sell
-10,800
Closed -$58K – 776
2021
Q4 		$58K Buy
+10,800
New +$52.6K ﹤0.01% 677

Other funds holding VRN

PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
OLVIG
Oliver Lagore Vanvalin Investment Group Flint, Michigan $255M AUM

Grantham, Mayo, Van Otterloo & Co (GMO)'s VRN Position: Q2 2025 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Veren (VRN) in Q2 2025, closing a stake of 3,908,929 shares — an estimated $25.9M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in VRN in Q4 2021 and held it in 10 quarters. The position peaked at $25.9M in Q1 2025. 2 funds tracked by Wall St. Rank hold VRN as of Q2 2025.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Veren position as of Q2 2025 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 3,908,929 Veren shares in Q2 2025, an estimated $25.9M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Veren in Q4 2021 and held it in 10 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Veren position peaked at $25.9M in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Veren as of Q2 2025.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2025, filed 13 Aug 2025.